Jens Bjørheim

820 total citations
26 papers, 680 citations indexed

About

Jens Bjørheim is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Jens Bjørheim has authored 26 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Biomedical Engineering. Recurrent topics in Jens Bjørheim's work include Molecular Biology Techniques and Applications (6 papers), Microfluidic and Capillary Electrophoresis Applications (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Jens Bjørheim is often cited by papers focused on Molecular Biology Techniques and Applications (6 papers), Microfluidic and Capillary Electrophoresis Applications (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Jens Bjørheim collaborates with scholars based in Norway, United States and Sweden. Jens Bjørheim's co-authors include Gustav Gaudernack, Per Olaf Ekstrøm, Ingvil Sæterdal, Marianne Klemp, Annika Lindblom, June H. Myklebust, Marek Minárik, Jon Amund Eriksen, Mona Møller and Kari Lislerud and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Analytical Biochemistry.

In The Last Decade

Jens Bjørheim

23 papers receiving 662 citations

Peers

Jens Bjørheim

ONCOL

IMMUN

PFM

Sandra D. Bohling United States

Hidetoshi Nakagawa Japan

Mirna Perusina Lanfranca United States

Chang Gon Kim South Korea

Joris van de Haar Netherlands

Guinebretière Jm France

Kari Lislerud Norway

James M. Leatherman United States

Weiqing Jing United States

Fumihiro Fujiki Japan

Sandra D. Bohling United States

Jens Bjørheim

211 ×0.6

ONCOL

209 ×0.8

141 ×0.7

IMMUN

208 ×1.1

PFM

63 ×0.6

Citations per year, relative to Jens Bjørheim Jens Bjørheim (= 1×) peers Sandra D. Bohling

Countries citing papers authored by Jens Bjørheim

Since Specialization

Citations

This map shows the geographic impact of Jens Bjørheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Bjørheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Bjørheim more than expected).

Fields of papers citing papers by Jens Bjørheim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Bjørheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Bjørheim. The network helps show where Jens Bjørheim may publish in the future.

Co-authorship network of co-authors of Jens Bjørheim

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Bjørheim. A scholar is included among the top collaborators of Jens Bjørheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Bjørheim. Jens Bjørheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lorigan, Paul, Theresa Medina, Marta Nyakas, et al.. (2024). Ipilimumab and nivolumab plus UV1, an anticancer vaccination against telomerase, in advanced melanoma.. Journal of Clinical Oncology. 42(17_suppl). LBA9519–LBA9519. 3 indexed citations

Bjørheim, Jens, et al.. (2023). Therapeutic cancer vaccination against telomerase: clinical developments in melanoma. Current Opinion in Oncology. 35(2). 100–106. 4 indexed citations

Gaudernack, Gustav, et al.. (2017). Telomerase peptide vaccine combined with ipilimumab in metastatic melanoma: Reports from a phase I trial. Annals of Oncology. 28. v410–v410.

Ekstrøm, Per Olaf, Jens Bjørheim, & William G. Thilly. (2007). Technology to accelerate pangenomic scanning for unknown point mutations in exonic sequences: cycling temperature capillary electrophoresis (CTCE). BMC Genetics. 8(1). 54–54. 12 indexed citations

Bjørheim, Jens, et al.. (2006). Tidsskriftet, ekstern fagvurdering og medisinsk publisering. Tidsskrift for Den Norske Laegeforening.

Ekstrøm, Per Olaf & Jens Bjørheim. (2006). Evaluation of sieving matrices used to separate alleles by cycling temperature capillary electrophoresis. Electrophoresis. 27(10). 1878–1885. 7 indexed citations

Bjørheim, Jens. (2006). Hjernens navigasjonssenter kartlegges. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

Bjørheim, Jens & Per Olaf Ekstrøm. (2005). Review of denaturant capillary electrophoresis in DNA variation analysis. Electrophoresis. 26(13). 2520–2530. 22 indexed citations

Bjørheim, Jens. (2004). Peptid med effekt på fedme. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

10.

Bjørheim, Jens, Gustav Gaudernack, Karl‐Erik Giercksky, & Per Olaf Ekstrøm. (2003). Direct identification of all oncogenic mutants in KRAS exon 1 by cycling temperature capillary electrophoresis. Electrophoresis. 24(1-2). 63–69. 23 indexed citations

11.

Bjørheim, Jens, et al.. (2003). Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 526(1-2). 75–83. 15 indexed citations

12.

Bjørheim, Jens, Marek Minárik, Gustav Gaudernack, & Per Olaf Ekstrøm. (2003). Evaluation of denaturing conditions in analysis of DNA variants applied to multi‐capillary electrophoresis instruments. Journal of Separation Science. 26(12-13). 1163–1168. 17 indexed citations

13.

Ekstrøm, Per Olaf, Jens Bjørheim, Gustav Gaudernack, & Karl-Erik Giercksky. (2002). Population Screening of Single-Nucleotide Polymorphisms Exemplified by Analysis of 8000 Alleles. SLAS DISCOVERY. 7(6). 501–506. 19 indexed citations

14.

Bjørheim, Jens, Marek Minárik, Gustav Gaudernack, & Per Olaf Ekstrøm. (2002). Mutation Detection in KRAS Exon 1 by Constant Denaturant Capillary Electrophoresis in 96 Parallel Capillaries. Analytical Biochemistry. 304(2). 200–205. 24 indexed citations

15.

Bjørheim, Jens, et al.. (2002). Detection of Mutations in Exon 8 of TP53 by Temperature Gradient 96-Capillary Array Electrophoresis. BioTechniques. 33(3). 650–653. 2 indexed citations

16.

Paulsen, Jan Erik, et al.. (2002). Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.. PubMed. 22(1A). 171–5. 5 indexed citations

17.

Bjørheim, Jens, et al.. (2002). Detection of Mutations in Exon 8 of TP53 by Temperature Gradient 96-Capillary Array Electrophoresis. BioTechniques. 33(3). 650–653. 25 indexed citations

18.

Kressner, Ulf, Jens Bjørheim, Siobhan Wahlberg, et al.. (1998). Ki-ras mutations and prognosis in colorectal cancer. European Journal of Cancer. 34(4). 518–521. 63 indexed citations

19.

Bjørheim, Jens, Annika Lindblom, Ulf Kressner, et al.. (1998). Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillaryelectrophoresis and allele specific polymerase chain reaction. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 403(1-2). 103–112. 50 indexed citations

20.

Klemp, Marianne, Jens Bjørheim, Ingvil Sæterdal, June H. Myklebust, & Gustav Gaudernack. (1997). Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. International Journal of Cancer. 72(5). 784–790. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact